Zoetis | ZTS - Eigenkapital Und Reserven

Aktienkurs
116.87
Täglich Wechseln
0.81 0.70%
Monatlich
0.14%
Jährlich
-23.85%
Q2 Prognose
114.37




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Bayer EUR 25.95B 3.75B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Coherus Biosciences USD 61.01M 26.76M 2025-12
Dentsply International USD 1.34B 139M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Henry Schein USD 3.24B 116M 2025-12
Idexx Laboratories USD 1.61B 44.2M 2025-12
Illumina USD 2.72B 342M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
J&J USD 81.19B 358M 2026-03
Laboratory Of America USD 8.62B 93.2M 2025-12
Merck USD 51.85B 2.79B 2025-09
Neogen USD 2.1B 2.09M 2025-12
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Quest Diagnostics USD 7.37B 196M 2026-03
Sanofi EUR 72.81B 1.1B 2026-03
Sanofi EUR 71.71B 14.25B 2025-12
Zoetis USD 3.33B 2.07B 2025-12